BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34388251)

  • 1. A comprehensive RNA editome reveals that edited Azin1 partners with DDX1 to enable hematopoietic stem cell differentiation.
    Wang F; He J; Liu S; Gao A; Yang L; Sun G; Ding W; Li CY; Gou F; He M; Wang F; Wang X; Zhao X; Zhu P; Hao S; Ma Y; Cheng H; Yu J; Cheng T
    Blood; 2021 Nov; 138(20):1939-1952. PubMed ID: 34388251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.
    Shigeyasu K; Okugawa Y; Toden S; Miyoshi J; Toiyama Y; Nagasaka T; Takahashi N; Kusunoki M; Takayama T; Yamada Y; Fujiwara T; Chen L; Goel A
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
    Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
    J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.
    Chen L; Li Y; Lin CH; Chan TH; Chow RK; Song Y; Liu M; Yuan YF; Fu L; Kong KL; Qi L; Li Y; Zhang N; Tong AH; Kwong DL; Man K; Lo CM; Lok S; Tenen DG; Guan XY
    Nat Med; 2013 Feb; 19(2):209-16. PubMed ID: 23291631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing.
    XuFeng R; Boyer MJ; Shen H; Li Y; Yu H; Gao Y; Yang Q; Wang Q; Cheng T
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17763-8. PubMed ID: 19805087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S; Shigeyasu K; Okugawa Y; Yoshida K; Mori Y; Yano S; Noma K; Umeda Y; Kondo Y; Kishimoto H; Teraishi F; Nagasaka T; Tazawa H; Kagawa S; Fujiwara T; Goel A
    Cancer Lett; 2019 Mar; 444():127-135. PubMed ID: 30583079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REDH: A database of RNA editome in hematopoietic differentiation and malignancy.
    Xu J; He J; Yang J; Wang F; Huo Y; Guo Y; Si Y; Gao Y; Wang F; Cheng H; Cheng T; Yu J; Wang X; Ma Y
    Chin Med J (Engl); 2024 Feb; 137(3):283-293. PubMed ID: 37386732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel computational method enables RNA editome profiling during human hematopoiesis from scRNA-seq data.
    Wu Y; Hao S; Xu X; Dong G; Ouyang W; Liu C; Sun HX
    Sci Rep; 2023 Jun; 13(1):10335. PubMed ID: 37365211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer.
    Nakamura K; Shigeyasu K; Okamoto K; Matsuoka H; Masuyama H
    Gynecol Oncol; 2022 Aug; 166(2):326-333. PubMed ID: 35697535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZIN1 RNA editing alters protein interactions, leading to nuclear translocation and worse outcomes in prostate cancer.
    Ghalali A; Wang L; Stopsack KH; Rice JM; Wu S; Wu CL; Zetter BR; Rogers MS
    Exp Mol Med; 2022 Oct; 54(10):1713-1726. PubMed ID: 36202978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA editome imbalance in hepatocellular carcinoma.
    Qi L; Chan TH; Tenen DG; Chen L
    Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer.
    Wei Y; Zhang H; Feng Q; Wang S; Shao Y; Wu J; Jin G; Lin W; Peng X; Xu X
    Cell Death Dis; 2022 Apr; 13(4):294. PubMed ID: 35365616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stop the dicing in hematopoiesis: what have we learned?
    Alemdehy MF; Erkeland SJ
    Cell Cycle; 2012 Aug; 11(15):2799-807. PubMed ID: 22801545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
    Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
    Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer.
    Tay DJT; Song Y; Peng B; Toh TB; Hooi L; Toh DK; Hong H; Tang SJ; Han J; Gan WL; Chan THM; Krishna MS; Patil KM; Maraswami M; Loh TP; Dan YY; Zhou L; Bonney GK; Chow PK; Chen G; Chow EK; Le MTN; Chen L
    Mol Ther; 2021 Nov; 29(11):3258-3273. PubMed ID: 33974998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers.
    Hu X; Chen J; Shi X; Feng F; Lau KW; Chen Y; Chen Y; Jiang L; Cui F; Zhang Y; Xu X; Li J
    Tumour Biol; 2017 Aug; 39(8):1010428317700001. PubMed ID: 28849733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation primes the murine kidney for recovery by activating AZIN1 adenosine-to-inosine editing.
    Heruye SH; Myslinski J; Zeng C; Zollman A; Makino S; Nanamatsu A; Mir Q; Janga SC; Doud EH; Eadon MT; Maier B; Hamada M; Tran TM; Dagher PC; Hato T
    J Clin Invest; 2024 Jul; ():. PubMed ID: 38954486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.